JPWO2021005129A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021005129A5 JPWO2021005129A5 JP2022501259A JP2022501259A JPWO2021005129A5 JP WO2021005129 A5 JPWO2021005129 A5 JP WO2021005129A5 JP 2022501259 A JP2022501259 A JP 2022501259A JP 2022501259 A JP2022501259 A JP 2022501259A JP WO2021005129 A5 JPWO2021005129 A5 JP WO2021005129A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- ibuprofen
- pharmaceutically acceptable
- composition according
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 22
- 229960001680 ibuprofen Drugs 0.000 claims 14
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 8
- TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 claims 5
- 229960004380 tramadol Drugs 0.000 claims 5
- TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 claims 5
- PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 claims 4
- 239000004475 Arginine Substances 0.000 claims 4
- 208000002193 Pain Diseases 0.000 claims 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 4
- 229960003107 tramadol hydrochloride Drugs 0.000 claims 4
- 239000007864 aqueous solution Substances 0.000 claims 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- 229940072056 alginate Drugs 0.000 claims 2
- 235000010443 alginic acid Nutrition 0.000 claims 2
- 229920000615 alginic acid Polymers 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 239000008187 granular material Substances 0.000 claims 2
- 239000003826 tablet Substances 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- IHHXIUAEPKVVII-ZSCHJXSPSA-N [(1s)-5-amino-1-carboxypentyl]azanium;2-[4-(2-methylpropyl)phenyl]propanoate Chemical compound OC(=O)[C@@H](N)CCCC[NH3+].CC(C)CC1=CC=C(C(C)C([O-])=O)C=C1 IHHXIUAEPKVVII-ZSCHJXSPSA-N 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 229940000425 combination drug Drugs 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19382583.3 | 2019-07-09 | ||
| EP19382583 | 2019-07-09 | ||
| PCT/EP2020/069306 WO2021005129A1 (en) | 2019-07-09 | 2020-07-08 | Combination of ibuprofen and tramadol for relieving pain |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022540854A JP2022540854A (ja) | 2022-09-20 |
| JPWO2021005129A5 true JPWO2021005129A5 (enExample) | 2023-07-19 |
| JP7656339B2 JP7656339B2 (ja) | 2025-04-03 |
Family
ID=67480112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022501259A Active JP7656339B2 (ja) | 2019-07-09 | 2020-07-08 | 疼痛を緩和するためのイブプロフェン及びトラマドールの組合せ |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20220249414A1 (enExample) |
| EP (1) | EP3996699B1 (enExample) |
| JP (1) | JP7656339B2 (enExample) |
| CN (1) | CN114080221B (enExample) |
| AU (1) | AU2020309160B2 (enExample) |
| BR (1) | BR112022000242A2 (enExample) |
| CA (1) | CA3145632C (enExample) |
| DK (1) | DK3996699T3 (enExample) |
| ES (1) | ES2952013T3 (enExample) |
| FI (1) | FI3996699T3 (enExample) |
| HR (1) | HRP20230677T1 (enExample) |
| HU (1) | HUE062529T2 (enExample) |
| MA (1) | MA56341B1 (enExample) |
| MD (1) | MD3996699T2 (enExample) |
| MX (1) | MX2022000373A (enExample) |
| MY (1) | MY207573A (enExample) |
| PL (1) | PL3996699T3 (enExample) |
| PT (1) | PT3996699T (enExample) |
| RS (1) | RS64500B1 (enExample) |
| SI (1) | SI3996699T1 (enExample) |
| WO (1) | WO2021005129A1 (enExample) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB971700A (en) | 1961-02-02 | 1964-09-30 | Boots Pure Drug Co Ltd | Anti-Inflammatory Agents |
| US3652589A (en) | 1967-07-27 | 1972-03-28 | Gruenenthal Chemie | 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols |
| GB1497044A (en) | 1974-03-07 | 1978-01-05 | Prodotti Antibiotici Spa | Salts of phenyl-alkanoic acids |
| US5516803A (en) * | 1991-10-30 | 1996-05-14 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| AU661723B2 (en) * | 1991-10-30 | 1995-08-03 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
| US20070117826A1 (en) * | 2005-11-23 | 2007-05-24 | Forest Laboratories, Inc. | Pharmaceutical formulations comprising ibuprofen, oxycodone, and 14-hydroxycodeinone |
| EP2149546A1 (en) * | 2008-07-31 | 2010-02-03 | Laboratorios Del. Dr. Esteve, S.A. | Salts of tramadol and ibuprofen and their crystal form in the treatment of pain |
| ES2356762B1 (es) * | 2009-09-04 | 2011-11-24 | Farmalider S.A. | Composicion farmaceutica de ibuprofeno, tramadol y un aminoacido basico, procedimiento para su preparacion y utilizacion de la misma. |
| ES2423866B1 (es) * | 2012-02-22 | 2014-06-10 | Farmalider, S.A. | Composición farmaceútica de ibuprofeno y tramadol para inyección |
| ES2540151B1 (es) * | 2013-10-11 | 2016-02-29 | Farmalider S.A. | Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico |
| WO2015157738A1 (en) * | 2014-04-10 | 2015-10-15 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
-
2020
- 2020-07-08 MY MYPI2021007550A patent/MY207573A/en unknown
- 2020-07-08 JP JP2022501259A patent/JP7656339B2/ja active Active
- 2020-07-08 SI SI202030232T patent/SI3996699T1/sl unknown
- 2020-07-08 BR BR112022000242A patent/BR112022000242A2/pt unknown
- 2020-07-08 MA MA56341A patent/MA56341B1/fr unknown
- 2020-07-08 FI FIEP20740266.0T patent/FI3996699T3/fi active
- 2020-07-08 PL PL20740266.0T patent/PL3996699T3/pl unknown
- 2020-07-08 HR HRP20230677TT patent/HRP20230677T1/hr unknown
- 2020-07-08 EP EP20740266.0A patent/EP3996699B1/en active Active
- 2020-07-08 RS RS20230732A patent/RS64500B1/sr unknown
- 2020-07-08 HU HUE20740266A patent/HUE062529T2/hu unknown
- 2020-07-08 PT PT207402660T patent/PT3996699T/pt unknown
- 2020-07-08 ES ES20740266T patent/ES2952013T3/es active Active
- 2020-07-08 MD MDE20220551T patent/MD3996699T2/ro unknown
- 2020-07-08 CA CA3145632A patent/CA3145632C/en active Active
- 2020-07-08 US US17/624,601 patent/US20220249414A1/en active Pending
- 2020-07-08 MX MX2022000373A patent/MX2022000373A/es unknown
- 2020-07-08 AU AU2020309160A patent/AU2020309160B2/en active Active
- 2020-07-08 CN CN202080049962.XA patent/CN114080221B/zh active Active
- 2020-07-08 DK DK20740266.0T patent/DK3996699T3/da active
- 2020-07-08 WO PCT/EP2020/069306 patent/WO2021005129A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (enExample) | ||
| JP6353577B2 (ja) | 組み合わせ組成物 | |
| JP2005515966A5 (enExample) | ||
| JP2018513188A5 (enExample) | ||
| JP2009102342A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2024075655A5 (ja) | 鏡像異性体的に純粋なブプロピオンの医薬の製造における使用 | |
| JP2017533211A5 (enExample) | ||
| JP2019501881A5 (enExample) | ||
| JP2008533127A5 (enExample) | ||
| JP2016505050A5 (enExample) | ||
| IL272834B1 (en) | Compositions of amantadine, their preparation, and methods of use | |
| JP2022177119A5 (enExample) | ||
| KR20120138229A (ko) | 정맥내 투여용 이부프로펜을 이용한 중증 환자의 치료 | |
| KR20120089623A (ko) | 정맥내 투여용 이부프로펜을 이용한 환자의 치료 | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| JP5386478B2 (ja) | パーキンソン病に伴う運動不全の治療のための４−シクロプロピルメトキシ−ｎ−（３，５−ジクロロ−１−オキシドピリジン−４−イル）−５−（メトキシ）ピリジン−２−カルボキサミドの使用 | |
| JPWO2021005129A5 (enExample) | ||
| JPWO2022107125A5 (enExample) | ||
| BR112020017773A2 (pt) | Composição farmacêutica compreendendo polmacoxibe e pregabalina para tratamento de dor | |
| JPWO2021089678A5 (enExample) | ||
| TH2201000080A (th) | การรวมกันของไอบูโพรเฟนและทรามาดอลสำหรับการบรรเทาอาการปวด | |
| RU2022102814A (ru) | Комбинация ибупрофена и трамадола для уменьшения боли | |
| JPWO2023043999A5 (enExample) |